These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7461672)

  • 21. Epidemiology of heart failure and left ventricular systolic dysfunction after acute myocardial infarction: prevalence, clinical characteristics, and prognostic importance.
    Weir RA; McMurray JJ; Velazquez EJ
    Am J Cardiol; 2006 May; 97(10A):13F-25F. PubMed ID: 16698331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [ACE inhibitors in the treatment of patients with acute myocardial infarct].
    Borghi C; Ambrosioni E
    Ann Ital Med Int; 1995; 10(3):175-87. PubMed ID: 7577315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prognostic significance of the hemodynamic response to vasodilator therapy in patients with acute myocardial infarct and cardiac insufficiency].
    Cantelli I; Pavesi PC; Lombardi G; Mengoli P; Vitolo A; Bracchetti D
    Minerva Cardioangiol; 1983 May; 31(5):261-8. PubMed ID: 6621890
    [No Abstract]   [Full Text] [Related]  

  • 24. Three-dimensional MRI assessment of regional wall stress after acute myocardial infarction predicts postdischarge cardiac events.
    Prunier F; Brette S; Delépine S; Geslin P; Le Jeune JJ; Furber AP
    J Magn Reson Imaging; 2008 Mar; 27(3):516-21. PubMed ID: 18224676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medical Grand Rounds from the University of Alabama Medical Center. Panel discussion on complications of acute myocardial infarction.
    South Med J; 1966 Oct; 59(10):1171-8. PubMed ID: 4958965
    [No Abstract]   [Full Text] [Related]  

  • 26. [Regional perfusion in heart failure. Changed distribution of blood flow caused by vasodilators].
    Drexler H
    Fortschr Med; 1987 Aug; 105(24):464-6. PubMed ID: 3653831
    [No Abstract]   [Full Text] [Related]  

  • 27. [Limitations of long-term treatment with vasodilator agents in increasing maximum functional capacity in patients with left ventricular insufficiency].
    Gronda E; Mafrici A; Ferrari D; Cataldo G; Salvadè P; Pirelli S; Mauri F; Faletra F; Carù B
    G Ital Cardiol; 1981; 11(6):803-11. PubMed ID: 7319186
    [No Abstract]   [Full Text] [Related]  

  • 28. Giant left ventricular pseudoaneurysm complicating an acute myocardial infarction in patient with previous cardiac surgery: a case report.
    Contuzzi R; Gatto L; Patti G; Goffredo C; D'Ambrosio A; Covino E; Chello M; Di Sciascio G
    J Cardiovasc Med (Hagerstown); 2009 Jan; 10(1):81-4. PubMed ID: 19145118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Use of vasodilators in the acute period of myocardial infarct].
    Vongvichit E
    Vrach Delo; 1981 Sep; (9):33-5. PubMed ID: 7303607
    [No Abstract]   [Full Text] [Related]  

  • 30. Differential alterations in left and right ventricular G-proteins in congestive heart failure due to myocardial infarction.
    Sethi R; Elimban V; Chapman D; Dixon IM; Dhalla NS
    J Mol Cell Cardiol; 1998 Nov; 30(11):2153-63. PubMed ID: 9925353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heart failure after acute myocardial infarction: a lost battle in the war on heart failure?
    Jhund PS; McMurray JJ
    Circulation; 2008 Nov; 118(20):2019-21. PubMed ID: 19001032
    [No Abstract]   [Full Text] [Related]  

  • 32. [Left ventricular insufficiency in the acute stage of myocardial infarct. Treatment by intravenous trinitrate].
    Le Pailleur C; Herrbach D; Lesourd P; Di Matteo J
    Nouv Presse Med; 1977 Apr; 6(13):1147-8. PubMed ID: 403507
    [No Abstract]   [Full Text] [Related]  

  • 33. Heart failure post-myocardial infarction: a review of the issues.
    Dargie H
    Heart; 2005 May; 91 Suppl 2(Suppl 2):ii3-6; discussion ii31, ii43-8. PubMed ID: 15831607
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of heart failure with vasodilator drugs].
    Pierach CA; Jarosch PF
    MMW Munch Med Wochenschr; 1974 Sep; 116(39):1689-90. PubMed ID: 4216778
    [No Abstract]   [Full Text] [Related]  

  • 35. Major adverse cardiac event predictors in survivors of myocardial infarction with asymptomatic left ventricular dysfunction or chronic heart failure.
    Kuch M; Janiszewski M; Mamcarz A; Cudnoch-Jedrzejewska A; Dłuzniewski M
    Med Sci Monit; 2009 Jun; 15(6):PH40-8. PubMed ID: 19478711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Vasodilation therapy].
    Widimský J
    Vnitr Lek; 1983 Mar; 29(3):274-82. PubMed ID: 6858011
    [No Abstract]   [Full Text] [Related]  

  • 37. [Captopril in the treatment of heart failure].
    Kékes E
    Acta Pharm Hung; 1997 Jul; 67(4):155-63. PubMed ID: 9289944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Infarction expansion and ventricular remodelling after acute myocardial infarction].
    Høst NB; Hansen PR
    Ugeskr Laeger; 1993 Oct; 155(43):3463-7. PubMed ID: 8256336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improving outcomes in post-acute myocardial infarction heart failure: incorporation of aldosterone blockade into combination therapy to optimize neurohormonal blockade.
    Pitt B; Fonarow GC; Gheorghiade M; Deedwania PC; Duprez DA
    Am J Cardiol; 2006 May; 97(10A):26F-33F. PubMed ID: 16698332
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phentolamine for vasodilator treatment of severe heart-failure.
    Majid PA; Sharma B; Taylor SH
    Lancet; 1971 Oct; 2(7727):719-24. PubMed ID: 4106226
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.